Pharma Journalist -

Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced that the FDA has approved IMKELDI (imatinib) oral solution, the first oral liquid form of imatinib…
Read More...

GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a regulatory application to extend the indication of Arexvy (respiratory syncytial virus…
Read More...

Kura Oncology, Inc. and Kyowa Kirin Co., Ltd. announced they have entered into a global strategic collaboration to develop and commercialize ziftomenib, Kura's selective oral menin…
Read More...

Zai Lab and Pfizer announced a strategic collaboration for the novel antibacterial drug XACDURO (sulbactam-durlobactam) in mainland China. Pfizer’s affiliated companies will be…
Read More...

Amneal Pharmaceuticals, Inc. announced the advancement of two key strategic initiatives. First, the Company has resubmitted to the U.S. Food and Drug Administration (FDA) its new drug…
Read More...

Enveda, a biotechnology company using AI to translate nature into new medicines, announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV with…
Read More...

Samsung Biologics announced a series of manufacturing deals with a Europe-based pharmaceutical company. The disclosed deals, worth over USD 668 million combined, will run through…
Read More...

Genprex, Inc., a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced it has entered into an exclusive…
Read More...

Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for HYMPAVZI (marstacimab) for the routine prophylaxis of bleeding episodes in patients 12…
Read More...

Alloy Therapeutics Inc., a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug discovery technologies, announced a strategic collaboration and license…
Read More...